Clinical Trials Browser

Phase 2 × Rectal Neoplasms × irinotecan sucrosofate × Clear all

NCT06210971 2025-03-13

Neoadjuvant Chemoradiation With Nal-IRI and Capecitabine Guided by UGT1A1 Status in Patients With Rectal Cancer

Phase 2 Recruiting

Gastrointestinal

Rectal Neoplasms